Results for "Specialty Pharmaceutical Distribution Facts, Figures, and Trends"
HDA Statement on the PREVENT Pandemics Act
The Healthcare Distribution Alliance (HDA) applauds the leadership of Senate Health, Education, Labor, and Pensions (HELP) Committee’s Chairwoman Murray (D-Wash.) and Ranking Member Burr (R-N.C.) for introducing the Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act (PREVENT Pandemics Act), a bipartisan public health effort to build stronger national medical preparedness and response systems in the wake of the COVID-19 pandemic. The overwhelming support for the legislation during the HELP Committee markup today, March 15, showed that Congress is making significant, positive steps towards reforms necessary to ensure the availability of lifesaving pharmaceutical treatments and medical supplies in response to future crises.
HDA Statement on FDA Enforcement Discretion for the DSCSA’s Final Implementation Requirements
The Healthcare Distribution Alliance (HDA) released a statement from President and CEO Chester “Chip” Davis, Jr., on the Food and Drug Administration’s (FDA) announcement that it plans to exercise enforcement discretion for the Drug Supply Chain Security Act’s (DSCSA) final implementation requirements.
HDA’s Chip Davis Assesses State of the Distribution Industry at 2021 BLC Online
HDA President and CEO Chip Davis recently spoke at the 2021 BLC Online about the unique role of the healthcare distribution industry in combating COVID-19, how distributors continue to rise to its challenges and what is still needed to turn the corner on the pandemic, among other association priorities.
Member Spotlight: When Distribution Is a Family Calling
While the business of pharmaceutical distribution has changed significantly over the past eight decades, HDA members like Capital Wholesale Drug Company (Capital Drug) have continued to play an essential role in providing safe and efficient healthcare delivery to trusted pharmacists and providers.